IDH3B encodes the beta subunit of mitochondrial NAD-dependent isocitrate dehydrogenase 3 (IDH3). The functional IDH3 enzyme is a heterotetramer with alpha2-beta-gamma stoichiometry (2alpha:1beta:1gamma), where the alpha subunits (IDH3A) are catalytic, while beta (IDH3B) and gamma (IDH3G) play structural and regulatory roles. IDH3B does NOT have intrinsic catalytic activity on its own - expression of beta subunit alone shows no detectable activity [PMID:10601238]. The alphabeta and alphagamma dimers exhibit significant IDH activity, but the full heterotetramer is required for maximal activity and proper allosteric regulation [PMID:14555658]. The IDH3 complex catalyzes the irreversible oxidative decarboxylation of isocitrate to alpha-ketoglutarate in the TCA cycle. Beta-Arg99 is required for normal ADP activation of the enzyme but is not essential for catalysis [PMID:14555658]. IDH3B localizes to the mitochondrial matrix. Biallelic variants cause retinitis pigmentosa 46 (RP46). IDH3B exists as multiple isoforms (beta1 and beta2) due to alternative splicing, with tissue-specific expression patterns affecting the pH optimum of the enzyme complex [PMID:10601238].
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005739
mitochondrion
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IDH3B is well-established as a mitochondrial protein. The IBA annotation is phylogenetically well-supported across eukaryotes. UniProt indicates a mitochondrial transit peptide (residues 1-34) and documents mitochondrial localization. PMID:10601238 describes IDH3B as part of "mitochondrial NAD(+)-dependent isocitrate dehydrogenase" and discusses its function in the context of mitochondrial enzyme complexes.
Reason: Mitochondrial localization is correct and well-supported by phylogenetic inference, UniProt annotation, and experimental literature. While mitochondrial matrix (GO:0005759) is more precise, this broader term is acceptable for the IBA evidence type.
Supporting Evidence:
PMID:10601238
the interactions and functional role of each of the three mitochondrial NAD(+)-dependent isocitrate dehydrogenase (IDH) subunits (alpha, beta, and gamma)
|
|
GO:0006099
tricarboxylic acid cycle
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IDH3B is a component of the NAD-dependent isocitrate dehydrogenase complex that catalyzes a key step of the TCA cycle. While the beta subunit is not itself catalytic, it is essential for proper complex assembly and function in the TCA cycle [PMID:10601238, PMID:14555658]. The IBA annotation appropriately captures the involvement of IDH3B in this process.
Reason: As an essential structural component of the IDH3 complex, IDH3B participates in the TCA cycle even though it lacks intrinsic catalytic activity. The phylogenetic evidence supports this annotation across eukaryotes.
Supporting Evidence:
PMID:10601238
Among the various combinations of human IDH subunits co-expressed in bacteria, alphabetagamma, alphabeta, and alphagamma combinations exhibited significant amounts of IDH activity
|
|
GO:0006102
isocitrate metabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IDH3B participates in isocitrate metabolism as part of the IDH3 complex. The complex converts isocitrate to alpha-ketoglutarate. While IDH3B is not the catalytic subunit, it is required for proper complex assembly and activity [PMID:10601238].
Reason: The annotation correctly captures IDH3B's involvement in isocitrate metabolism through its role in the IDH3 complex. Well-supported by phylogenetic analysis.
Supporting Evidence:
PMID:10601238
the alpha is the catalytic subunit and that at least one of the other two subunits plays an essential supporting role for activity
|
|
GO:0000287
magnesium ion binding
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: This annotation is inferred from InterPro domain IPR019818 (IsoCit/isopropylmalate_DH_CS). However, in the IDH3 complex, Mg2+ (or Mn2+) binding occurs at the active site in the catalytic alpha subunit, not in the structural beta subunit. The deep research notes that the enzyme "is a heterooctamer containing two copies of a heterotetramer of two IDH3A, one IDH3B, one IDH3G, and two Mn++" [Reactome:R-HSA-70967], suggesting metal binding is associated with the catalytic subunits. No direct evidence supports magnesium binding by IDH3B specifically. The crystal structures of the αβ heterodimer (PDB 6KDE Ca2+-bound, 6KDY NAD-bound) place the divalent metal site at the active-site cleft contributed by the α subunit; the β subunit does not provide a productive metal site, and in the αβ heterodimer the active site has a distorted geometry unable to bind the metal ion in a catalysis-relevant manner [PMID:31515270].
Reason: While the InterPro domain is present, the functional magnesium/metal binding site is located in the catalytic alpha subunit. IDH3B shares sequence/structural homology with dehydrogenases but its specific role is structural, not catalytic. This IEA annotation represents domain-based inference that does not reflect the actual function of this specific subunit.
Supporting Evidence:
PMID:31515270
the active site has a distorted geometry that is unable to bind the metal ion effectively or in a catalysis-relevant manner
|
|
GO:0005739
mitochondrion
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Mitochondrial localization inferred from UniProt subcellular location annotation. This is consistent with experimental evidence and the IBA annotation above.
Reason: Correct annotation based on UniProt curation. IDH3B has a mitochondrial transit peptide and functions in the mitochondrial matrix.
|
|
GO:0006099
tricarboxylic acid cycle
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Combined automated annotation correctly identifies IDH3B's involvement in the TCA cycle. Consistent with IBA annotation and experimental literature.
Reason: Correct annotation. IDH3B is part of the IDH3 complex that catalyzes a key TCA cycle step.
|
|
GO:0016616
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
IEA
GO_REF:0000002 |
REMOVE |
Summary: This annotation is inferred from InterPro domain IPR019818. However, PMID:10601238 demonstrates that "subunits produced alone ... showed no detectable activity" and establishes that "the alpha is the catalytic subunit." IDH3B shares the dehydrogenase domain but does not itself possess oxidoreductase activity - it is a structural/ regulatory subunit of the complex.
Reason: IDH3B does not have intrinsic oxidoreductase activity. The beta subunit alone shows no detectable enzymatic activity [PMID:10601238]. This annotation incorrectly attributes the catalytic activity of the complex to the non-catalytic beta subunit based solely on domain homology.
Supporting Evidence:
PMID:10601238
subunits produced alone and betagamma showed no detectable activity. These data suggest that the alpha is the catalytic subunit
|
|
GO:0051287
NAD binding
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: This annotation is inferred from InterPro domain IPR019818. While IDH3B shares structural homology with NAD-binding dehydrogenases, the functional NAD binding and catalysis occurs in the alpha subunit. PMID:14555658 shows that mutations in the gamma subunit affect NAD binding (gamma-R97Q has 10-fold higher Km for NAD), but the beta subunit's role is in ADP activation, not NAD binding at the catalytic site. However, the beta subunit may contribute to the nucleotide binding pocket architecture.
Reason: The annotation is based on domain homology rather than demonstrated function. IDH3B contributes to the complex structure and ADP-mediated regulation but is not itself the primary NAD-binding subunit. The catalytic NAD binding site is in IDH3A. Crystal structures of the alphabeta heterodimer (PDB 6KDY NAD-bound, 6KE3 NADH-bound) show that the NAD cofactor binds in the active-site cleft built jointly from the alpha subunit and the small domain of the beta subunit, so the beta subunit contributes to the architecture of the holoenzyme NAD-binding/active site rather than binding NAD as an isolated subunit [PMID:31515270].
Supporting Evidence:
PMID:14555658
the beta and gamma subunits have roles in the nucleotide functions of this allosteric enzyme
PMID:31515270
We report here the crystal structures of the αβ heterodimer of human NAD-IDH with the α subunit in apo form and in Ca2+-bound, NAD-bound, and NADH-bound forms
PMID:31515270
The active site is located in the cleft formed by the large and small domains of the α subunit and the small domain of the β subunit
PMID:36375638
the αQ139AICT+Ca+NADβNAD structure presents the first pseudo-Michaelis complex of HsIDH3, which allows us to identify the key residues involved in the binding of cofactor, substrate, and metal ion
|
|
GO:0045242
isocitrate dehydrogenase complex (NAD+)
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IDH3B is a core component of the NAD-dependent isocitrate dehydrogenase complex. The complex has 2alpha:1beta:1gamma stoichiometry [PMID:14555658]. This cellular component annotation is entirely appropriate for IDH3B. Crystal structures of the human IDH3 alphabeta heterodimer (PDB 6KDE/6KDF/6KDY/6KE3) and of the constitutively active (αβαγ)2 holoenzyme (PDB 8GRB) directly establish IDH3B (beta) as an assembled subunit of the IDH3 complex and define the alpha-beta heterodimer interface [PMID:31515270, PMID:36375638].
Reason: Correct annotation. IDH3B is an established subunit of the IDH3 complex, confirmed by co-expression studies and structural analysis.
Supporting Evidence:
PMID:14555658
Wild type (WT) and mutant enzymes ... were purified to homogeneity yielding enzymes with 2alpha:1beta:1gamma subunit composition
PMID:31515270
The α and β subunits form a heterodimer (αβ), and the α and γ subunits form another heterodimer (αγ), which are assembled into a heterotetramer (α2βγ) and further into a heterooctamer
PMID:36375638
It consists of three types of subunits (α, β, and γ) and exists and functions as the (αβαγ)2 heterooctamer
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: Direct experimental evidence for mitochondrial localization from HPA immunofluorescence data. This provides direct experimental support for the mitochondrial localization.
Reason: Direct experimental evidence (IDA from immunofluorescence) confirms mitochondrial localization, consistent with all other evidence sources.
|
|
GO:0005739
mitochondrion
|
NAS
PMID:14555658 Evaluation by mutagenesis of the importance of 3 arginines i... |
ACCEPT |
Summary: PMID:14555658 is a study of human NAD-dependent isocitrate dehydrogenase expressed in bacteria. The paper discusses the enzyme's function in the context of mitochondrial metabolism but does not directly demonstrate mitochondrial localization - hence NAS (non-traceable author statement) is appropriate.
Reason: While the evidence is indirect, mitochondrial localization is well-established from multiple other sources. This annotation is consistent with the overall body of evidence.
Supporting Evidence:
PMID:14555658
Mammalian NAD-dependent isocitrate dehydrogenase is an allosteric enzyme
|
|
GO:0006099
tricarboxylic acid cycle
|
IDA
PMID:14555658 Evaluation by mutagenesis of the importance of 3 arginines i... |
ACCEPT |
Summary: PMID:14555658 demonstrates that the IDH3 complex including the beta subunit has isocitrate dehydrogenase activity, which is a key TCA cycle reaction. The study shows IDH activity of purified complexes containing beta subunit [PMID:14555658].
Reason: Direct experimental evidence that IDH3B-containing complexes have isocitrate dehydrogenase activity, supporting involvement in TCA cycle.
Supporting Evidence:
PMID:14555658
Specific activities of 22, 14, and 2 micromol of NADH/min/mg were measured, respectively, for WT, beta-R99Q, and gamma-R97Q enzymes
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
ACCEPT |
Summary: PMID:34800366 is a high-throughput mitochondrial proteomics study that identified IDH3B in the human mitochondrial proteome. This provides orthogonal mass spectrometry- based evidence for mitochondrial localization.
Reason: High-quality proteomics study confirming IDH3B presence in the mitochondrial proteome.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome
|
|
GO:0045242
isocitrate dehydrogenase complex (NAD+)
|
IDA
PMID:14555658 Evaluation by mutagenesis of the importance of 3 arginines i... |
ACCEPT |
Summary: PMID:14555658 provides direct experimental evidence that IDH3B is a component of the IDH3 complex. The study purified the complex and demonstrated the 2alpha:1beta:1gamma stoichiometry through expression and biochemical analysis. Crystal structures of the human IDH3 alphabeta heterodimer (PDB 6KDE/6KDF/6KDY NAD-bound/6KE3 NADH-bound) and of the constitutively active (alphabeta-alphagamma)2 holoenzyme (PDB 8GRB) directly visualize IDH3B (beta) as an assembled subunit of the IDH3 complex and define the alpha-beta heterodimer interface [PMID:31515270, PMID:36375638].
Reason: Direct experimental demonstration that IDH3B is part of the IDH3 complex with defined stoichiometry.
Supporting Evidence:
PMID:14555658
Wild type (WT) and mutant enzymes (each containing 2 normal subunits plus a mutant subunit with alpha-R88Q, beta-R99Q, or gamma-R97Q) were purified to homogeneity yielding enzymes with 2alpha:1beta:1gamma subunit composition and a native molecular mass of 315 kDa
PMID:31515270
The α and β subunits form a heterodimer (αβ), and the α and γ subunits form another heterodimer (αγ), which are assembled into a heterotetramer (α2βγ) and further into a heterooctamer
PMID:36375638
It consists of three types of subunits (α, β, and γ) and exists and functions as the (αβαγ)2 heterooctamer
|
|
GO:0005634
nucleus
|
HDA
PMID:21630459 Proteomic characterization of the human sperm nucleus. |
KEEP AS NON CORE |
Summary: PMID:21630459 is a proteomic study of the human sperm nucleus that identified IDH3B among 403 nuclear proteins. This is a specialized cell type where metabolic proteins may be present in the nuclear fraction during spermatogenesis. The nuclear localization is likely context-specific rather than representing a core localization.
Reason: The detection in sperm nuclear proteome may represent a specialized developmental context. IDH3B's primary localization is mitochondrial, and nuclear detection may reflect the unique chromatin remodeling during spermiogenesis or technical co-purification. This is not a core localization but should be retained.
Supporting Evidence:
PMID:21630459
403 different proteins have been identified from the isolated sperm nuclei
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-70967 |
ACCEPT |
Summary: Reactome pathway R-HSA-70967 "IDH3 complex decarboxylates isocitrate" places the IDH3 complex, including IDH3B, in the mitochondrial matrix. This is the most specific and accurate localization for IDH3B's function.
Reason: Mitochondrial matrix is the precise subcellular location where IDH3 functions in the TCA cycle. This is the most informative localization annotation for IDH3B.
|
|
GO:0009055
electron transfer activity
|
TAS
PMID:10601238 Identification and functional characterization of a novel, t... |
REMOVE |
Summary: PMID:10601238 does not support electron transfer activity for IDH3B. The paper demonstrates that the IDH3 complex has isocitrate dehydrogenase activity (reducing NAD+ to NADH), but this is not the same as electron transfer activity. Electron transfer activity (GO:0009055) refers to proteins that function as electron carriers (like cytochromes or ferredoxins), not dehydrogenases that use NAD+ as a cofactor. Furthermore, IDH3B specifically is the non-catalytic subunit.
Reason: Incorrect annotation. GO:0009055 (electron transfer activity) is inappropriate for IDH3B. The NAD+-dependent dehydrogenase reaction is not electron transfer activity in the GO sense. Additionally, IDH3B is not catalytically active - the paper states "subunits produced alone ... showed no detectable activity."
Supporting Evidence:
PMID:10601238
subunits produced alone and betagamma showed no detectable activity
|
|
GO:0004449
isocitrate dehydrogenase (NAD+) activity
|
TAS
PMID:10601238 Identification and functional characterization of a novel, t... |
REMOVE |
Summary: PMID:10601238 explicitly demonstrates that IDH3B alone does not have isocitrate dehydrogenase activity. The paper states "subunits produced alone and betagamma showed no detectable activity" and concludes that "the alpha is the catalytic subunit." While the alphabeta dimer has activity, this is due to the alpha subunit, not beta.
Reason: The cited paper PMID:10601238 directly contradicts this annotation. IDH3B does not have intrinsic isocitrate dehydrogenase activity. The beta subunit is structural/ regulatory, and attributing the catalytic activity to it is incorrect. This is a case where the annotation was likely made at the complex level and incorrectly propagated to the non-catalytic subunit.
Supporting Evidence:
PMID:10601238
subunits produced alone and betagamma showed no detectable activity. These data suggest that the alpha is the catalytic subunit and that at least one of the other two subunits plays an essential supporting role for activity
|
|
GO:0005739
mitochondrion
|
TAS
PMID:10601238 Identification and functional characterization of a novel, t... |
ACCEPT |
Summary: PMID:10601238 describes IDH3B as part of "mitochondrial NAD(+)-dependent isocitrate dehydrogenase" and discusses it in the context of mitochondrial function. The mitochondrial localization is well-supported.
Reason: The paper describes IDH3B as a mitochondrial protein. Consistent with all other evidence for mitochondrial localization.
Supporting Evidence:
PMID:10601238
the interactions and functional role of each of the three mitochondrial NAD(+)-dependent isocitrate dehydrogenase (IDH) subunits
|
|
GO:0006102
isocitrate metabolic process
|
TAS
PMID:10601238 Identification and functional characterization of a novel, t... |
ACCEPT |
Summary: PMID:10601238 demonstrates that IDH3B contributes to isocitrate metabolism as part of the IDH3 complex. While IDH3B is not catalytic, it plays "an essential supporting role for activity" in isocitrate oxidation.
Reason: IDH3B participates in isocitrate metabolism through its essential structural role in the IDH3 complex. The paper demonstrates that beta-containing complexes have isocitrate dehydrogenase activity.
Supporting Evidence:
PMID:10601238
alphabetagamma, alphabeta, and alphagamma combinations exhibited significant amounts of IDH activity
|
|
GO:0005198
structural molecule activity
|
NAS
PMID:10601238 Identification and functional characterization of a novel, t... |
NEW |
Summary: IDH3B functions as a structural subunit of the IDH3 complex. PMID:10601238 demonstrates that the beta subunit alone has no catalytic activity ("subunits produced alone and betagamma showed no detectable activity") but plays "an essential supporting role for activity." The beta subunit is required for proper complex assembly and function. Deep research confirms that IDH3B plays a structural/regulatory role in the heterotetramer [file:human/IDH3B/IDH3B-deep-research-falcon.md].
Reason: This annotation captures IDH3B's established role as a structural component of the IDH3 enzyme complex. The term GO:0005198 is defined as "The action of a molecule that contributes to the structural integrity of a complex" which accurately describes IDH3B's function. This is a more appropriate molecular function annotation than the catalytic activity terms that were incorrectly attributed to IDH3B.
Supporting Evidence:
PMID:10601238
These data suggest that the alpha is the catalytic subunit and that at least one of the other two subunits plays an essential supporting role for activity
file:human/IDH3B/IDH3B-deep-research-falcon.md
IDH3B appears to play a structural/regulatory role in the complex, as opposed to a catalytic one
|
Q: Within the αβαγ heterotetramer (and its (αβαγ)2 holoenzyme), which IDH3B residues beyond β-Arg99 transmit the ADP allosteric signal to the IDH3A catalytic site, and does IDH3B contribute any direct interactions to substrate/cofactor binding in the pseudo-Michaelis complex captured by the αQ139A·ICT·Ca·NAD·βNAD structure (PMID:36375638)? Mapping these residues would justify more specific molecular-function annotations for IDH3B (e.g., positive regulation of isocitrate dehydrogenase activity).
Q: What is the functional consequence of β1 vs β2 isoform switching in vivo? Beyond the shifted pH optimum from 8.0 to 7.6 in vitro (PMID:10601238), do heart and skeletal muscle preferentially run IDH3 at distinct intramitochondrial pH set points, and is this isoform exchange dynamic with physiological state (exercise, ischemia)?
Q: Why does loss of IDH3B selectively manifest as retinitis pigmentosa 46 when IDH3 operates ubiquitously? Is the retinal phenotype driven by a uniquely high photoreceptor TCA flux, by altered NADH/NAD+ balance affecting outer-segment lipid/visual-cycle pathways, or by α2γ-only complexes acting as a partial-loss-of- function background that other tissues tolerate?
Experiment: Reconstitute the recombinant (αβαγ)2 holoenzyme with IDH3B variants spanning the β3-α3 and β12-α8 loops identified in PMID:31515270 / PMID:36375638 as building the pseudo-allosteric site, and measure ADP-dependent k_cat / K_m for isocitrate plus ADP-binding affinity by ITC. Pair with cryo-EM of selected variants in the apo and ADP-bound states to confirm structural consequences.
Hypothesis: The pseudo-allosteric loops contributed by IDH3B (small domain plus β3-α3 / β12-α8) are the principal transducers of ADP activation, and engineered residue swaps in these loops can uncouple ADP binding from catalytic activation.
Type: biochemistry / structural biology
Experiment: Generate isoform-specific β1 and β2 CRISPR knock-in HEK293, C2C12 (skeletal muscle) and HL-1 (cardiomyocyte) lines and measure intramitochondrial pH, TCA flux (13C isotopologue analysis of citrate/α-ketoglutarate), and oxygen consumption under basal and exercised/hypoxic conditions.
Hypothesis: β2 expression in muscle tissue tunes IDH3 activity to a lower, physiologically relevant matrix pH, supporting sustained TCA flux during high-workload conditions where matrix pH falls below the β1 optimum.
Type: cell biology / metabolomics
Experiment: Patient-derived iPSC differentiation to retinal organoids from RP46 IDH3B patients vs. isogenic CRISPR-corrected controls, with assessment of photoreceptor survival, outer-segment morphology, NADH/NAD+ ratio, α-KG levels, and TCA flux. Compare to iPSC-derived cardiomyocytes and hepatocytes from the same patients to identify the metabolic axis that distinguishes the retina.
Hypothesis: Photoreceptor degeneration in RP46 is driven by NADH-dependent or α-KG-dependent processes uniquely sensitive to partial IDH3 activity (e.g., visual-cycle retinoid metabolism or HIF/2-oxoglutarate-dependent dioxygenase signalling) rather than by a generalized TCA failure.
Type: stem-cell biology / clinical model
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan status update: We verified the target identity and collected recent, authoritative sources focused on the human IDH3B subunit of mitochondrial isocitrate dehydrogenase 3 (IDH3). We synthesized functional, mechanistic, localization, regulation, disease, and quantitative data, prioritizing 2022–2024 peer‑reviewed literature where available.
Comprehensive Research Report: Human IDH3B (UniProt: O43837)
1) Key concepts and definitions
- Identity and gene/protein verification: IDH3B encodes the beta subunit of the mitochondrial NAD-dependent isocitrate dehydrogenase 3 complex (IDH3). IDH3 catalyzes the irreversible oxidative decarboxylation of isocitrate to alpha‑ketoglutarate (α‑KG) and CO2, reducing NAD+ to NADH in the tricarboxylic acid (TCA) cycle. These features distinguish IDH3 (NAD+-dependent, mitochondrial) from IDH1/2 (NADP+-dependent; IDH1 cytosolic/peroxisomal; IDH2 mitochondrial) (https://doi.org/10.1016/j.jbc.2022.102387, Sep 2022; https://doi.org/10.1242/dmm.036426, Dec 2018; https://doi.org/10.3390/cancers15112883, May 2023) (zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
- Organism confirmation: All cited primary and review sources explicitly address mammalian/human IDH3 and subunits including IDH3B (https://doi.org/10.1016/j.jbc.2022.102387; https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
- Family/domains alignment: IDH3B belongs to the mitochondrial isocitrate dehydrogenase 3 family and carries conserved isocitrate dehydrogenase domains shared with the IsoCit/isopropylmalate_DH clan; the beta subunit plays primarily structural/regulatory roles within the complex (https://doi.org/10.1016/j.jbc.2022.102387; https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
2) Molecular function, reaction, substrate specificity, and localization
- Enzymatic reaction: IDH3 catalyzes isocitrate + NAD+ → α‑KG + CO2 + NADH. Unlike IDH1/2, IDH3 is NAD+-specific and functions in the canonical TCA cycle (https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
- Substrate/cofactor specificity: Substrate is isocitrate; cofactor is NAD+. The reaction is physiologically irreversible in the TCA direction under mitochondrial conditions (https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
- Complex composition/stoichiometry: Functional IDH3 is an α2βγ heterotetramer; α subunits are catalytic, β (IDH3B) contributes structural/assembly functions and influences allosteric regulation, and γ (IDH3G) has key allosteric roles (https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
- Localization: IDH3 resides in the mitochondrial matrix. Expression is enriched in mitochondria‑rich tissues (e.g., heart, skeletal muscle, brain, retina) (https://doi.org/10.1016/j.jbc.2022.102387; https://doi.org/10.1242/dmm.036426) (zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 4-6).
3) Biochemical pathway context and regulation
- Pathway role: IDH3 is a central, rate‑influencing step of the TCA cycle, producing α‑KG and mitochondrial NADH that fuels oxidative phosphorylation. By managing α‑KG levels, IDH3 impacts α‑KG–dependent dioxygenase activities with downstream epigenetic effects noted in development and reprogramming contexts (https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 9-10).
- Regulation/allostery: IDH3 activity is modulated by cellular energy and redox state. Reported activators include citrate/isocitrate, ADP, NAD+, and divalent cations (Mg2+, Mn2+, Ca2+), while inhibitors include NADH, α‑KG, and ATP; the β and γ subunits set effector sensitivity. Distinct activities have been measured for partial dimers vs. the heterotetramer (α–γ dimer ~36% of tetramer activity; α–β dimer ~16%), indicating subunit‑dependent regulation (https://doi.org/10.3390/cancers15112883; https://doi.org/10.1242/dmm.036426) (solomou2023mutantidhin pages 1-2, findlay2018mouseidh3amutations pages 11-13).
4) Structure–function, assembly, and quantitative data
- Subunit activities and assembly: Biochemical studies demonstrate differing specific activities of αγ and αβ dimers relative to the α2βγ tetramer, consistent with non‑catalytic subunits tuning activity and allosteric responses (α–γ ≈ 36%; α–β ≈ 16% of tetramer) (https://doi.org/10.1242/dmm.036426) (findlay2018mouseidh3amutations pages 11-13).
- Tissue‑specific compensation: In Idh3b knockout mice, testes show coordinated subunit expression changes (e.g., ~75% reduction in IDH3A and ~35% increase in IDH3G), illustrating tissue‑specific assembly compensation and dependence (https://doi.org/10.1016/j.jbc.2022.102387) (zhu2022isocitratedehydrogenase3b pages 1-2).
- Mitochondrial reserve capacity: Photoreceptor mitochondria operate near their maximal respiratory rate (~70–80%), leaving low reserve; this helps explain retinal vulnerability to partial IDH3 dysfunction (https://doi.org/10.1242/dmm.036426) (findlay2018mouseidh3amutations pages 4-6).
5) Recent developments and latest research (priority 2023–2024)
- 2023 review of mutant IDH and physiology: Comprehensive discussion of IDH family biology emphasizes IDH3’s role in the mitochondrial TCA cycle, subunit functions (α catalytic; β structural; γ allosteric), and lack of canonical tumor‑driver mutations in IDH3 subunits compared to IDH1/2 (https://doi.org/10.3390/cancers15112883, May 2023) (solomou2023mutantidhin pages 1-2).
- Developmental/epigenetic context: Emerging work summarized in recent reviews indicates that IDH enzymes (notably IDH3A) can transiently localize to the nucleus during early development/reprogramming, implicating mitochondrial‑nuclear metabolic coupling; although shown for IDH3A, this underscores systems‑level roles of the IDH3 complex composition that includes β (IDH3B) (https://doi.org/10.3390/cancers15112883, May 2023) (solomou2023mutantidhin pages 9-10).
- 2022 functional genetics in mammals (near‑current and highly relevant): IDH3B is essential for spermiogenesis in mice, with loss causing male infertility but not retinal degeneration, refining tissue‑specific functional annotation of IDH3B (https://doi.org/10.1016/j.jbc.2022.102387, Sep 2022) (zhu2022isocitratedehydrogenase3b pages 1-2).
6) Disease associations, genetics, and clinical relevance
- Inherited retinal disease (IRD): Biallelic IDH3B variants have been reported in families with nonsyndromic retinitis pigmentosa; experimental mouse Idh3a and human genetics highlight retinal susceptibility to IDH3 perturbation, consistent with high mitochondrial load in photoreceptors (https://doi.org/10.1242/dmm.036426, Dec 2018) (findlay2018mouseidh3amutations pages 4-6).
- Species differences: Despite human reports, Idh3b−/− mice do not show retinal degeneration or impaired mitochondrial respiration in embryonic fibroblasts through P180, illustrating species and tissue‑specific differences and potential compensation (https://doi.org/10.1242/dmm.036426, Dec 2018) (findlay2018mouseidh3amutations pages 8-11).
- Spermatogenesis/male infertility: Genetic ablation of Idh3b in mice reveals a critical requirement for spermiogenesis; IDH3B deficiency impairs sperm development and is linked to reduced IDH3A protein and compensatory IDH3G increase in testes (https://doi.org/10.1016/j.jbc.2022.102387, Sep 2022) (zhu2022isocitratedehydrogenase3b pages 1-2).
- Broader clinical context: IDH3 subunit defects (especially IDH3A/IDH3B) are increasingly recognized in IRD gene panels and reviews of metabolic contributions to disease, although IDH3 subunits are not the canonical IDH1/2 cancer drivers (https://doi.org/10.3390/cancers15112883, May 2023) (solomou2023mutantidhin pages 1-2).
7) Current applications and implementations
- Diagnostics: Genetic testing for IRDs includes IDH3 subunits in gene panels; assignment of pathogenicity requires careful segregation, functional data, and attention to species‑specific phenotypic differences inferred from model systems (https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
- Research models: Idh3a and Idh3b mouse models provide complementary tools for dissecting retinal bioenergetics and spermatogenesis; extracellular flux assays in mutant fibroblasts illustrate how reserve capacity and maximal respiration are used to profile mitochondrial consequences of subunit loss (https://doi.org/10.1242/dmm.036426; https://doi.org/10.1016/j.jbc.2022.102387) (findlay2018mouseidh3amutations pages 8-11, zhu2022isocitratedehydrogenase3b pages 1-2).
8) Expert opinions/analysis from authoritative sources
- Consensus function: Primary biochemical role and mitochondrial localization of IDH3 (with IDH3B as the β subunit) are well‑established and consistently described in peer‑reviewed primary and review articles (https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
- Regulatory architecture: Subunit architecture underlies nuanced allosteric regulation—γ and β modulate catalytic α activity and effector sensitivity—fitting the broader theme that energy/redox sensing is embedded in IDH3 quaternary structure (https://doi.org/10.3390/cancers15112883) (solomou2023mutantidhin pages 1-2).
- Disease interpretation: The divergence between human retinal phenotypes and mouse Idh3b retinal viability suggests that in humans, β‑subunit loss reduces functional tetramer abundance/efficacy sufficiently to cross a disease threshold in photoreceptors, whereas mice may compensate via subunit rebalancing or metabolic plasticity (https://doi.org/10.1242/dmm.036426; https://doi.org/10.1016/j.jbc.2022.102387) (findlay2018mouseidh3amutations pages 4-6, zhu2022isocitratedehydrogenase3b pages 1-2).
9) Quantitative statistics and data
- Partial dimer activity vs tetramer: αγ dimer ≈ 36% and αβ dimer ≈ 16% of heterotetramer specific activity in vitro, showing the importance of tetramer assembly for full catalytic throughput (https://doi.org/10.1242/dmm.036426) (findlay2018mouseidh3amutations pages 11-13).
- Photoreceptor bioenergetics: Photoreceptor mitochondria reportedly function at ~70–80% of maximal capacity in vivo, rationalizing sensitivity to reduced IDH3 flux (https://doi.org/10.1242/dmm.036426) (findlay2018mouseidh3amutations pages 4-6).
- Testis subunit re‑balancing in IDH3B loss: In Idh3b−/− mice, IDH3A decreases by ~75% and IDH3G increases by ~35% in testes, aligning with defective spermiogenesis and suggesting assembly‑dependent stability (https://doi.org/10.1016/j.jbc.2022.102387) (zhu2022isocitratedehydrogenase3b pages 1-2).
Embedded summary artifact
| Topic | Key points | Quantitative / structural details | Most supportive sources |
|---|---|---:|---|
| Identity & domains | IDH3B encodes the beta (non‑catalytic/structural) subunit of mitochondrial NAD‑dependent isocitrate dehydrogenase 3 (IDH3); domain annotations include IsoCit/isopropylmalate_DH_CS and Isocitrate_DH_NAD. | UniProt accession O43837 (IDH3B); contains conserved isocitrate dehydrogenase domains typical of IDH3 family. | (zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 4-6) |
| Enzymatic reaction & specificity | IDH3 complex catalyzes irreversible oxidative decarboxylation: isocitrate → α‑ketoglutarate (α‑KG) with reduction of NAD+ → NADH. IDH3B is part of the NAD+‑dependent enzyme (distinct from NADP+ IDH1/2). | Reaction: isocitrate + NAD+ → α‑KG + CO2 + NADH; IDH3 is NAD+‑specific. | (findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2) |
| Complex composition / stoichiometry | Functional enzyme is a heterotetramer comprising two α subunits plus one β (IDH3B) and one γ subunit (IDH3G); β has structural/regulatory role. | Stoichiometry: α2β1γ1 (heterotetramer). β contributes to assembly/allostery rather than primary catalysis. | (findlay2018mouseidh3amutations pages 4-6, findlay2018mouseidh3amutations pages 11-13) |
| Localization | Localizes to the mitochondrial matrix; expressed highly in mitochondria‑rich tissues (heart, skeletal muscle, brain, retina). | Mitochondrial targeting and matrix localization reported in mammalian tissues. | (zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 4-6) |
| Allosteric regulation | IDH3 activity is regulated allosterically (substrate/cofactor and energy state); β/γ subunits modulate sensitivity to effectors. | Activated by isocitrate/ADP/NAD+/divalent cations (Mg2+/Mn2+/Ca2+); inhibited by NADH, α‑KG, ATP; β/γ subunits shape these responses. | (solomou2023mutantidhin pages 1-2, findlay2018mouseidh3amutations pages 11-13) |
| Pathway context (TCA / NADH) | IDH3 provides α‑KG for TCA and produces NADH used in oxidative phosphorylation; by controlling α‑KG, it can indirectly affect α‑KG‑dependent dioxygenases/epigenetic processes. | Position: canonical TCA step (isocitrate → α‑KG) supplying reducing equivalents (NADH) to complex I/ETC. | (findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 9-10) |
| Disease associations | Human biallelic/homozygous IDH3B variants reported in families with retinitis pigmentosa; IDH3B loss also linked to impaired spermiogenesis/male infertility in experimental models. | Human: familial RP linked to IDH3B loss‑of‑function alleles; experimental mouse: Idh3b KO causes spermiogenesis defects (Zhu et al. 2022). | (findlay2018mouseidh3amutations pages 4-6, zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 8-11) |
| Model organism contrasts | Humans with IDH3B null variants reported retinal degeneration; mouse Idh3b knockout is viable with no retinal degeneration but shows male fertility defects; Idh3a loss is embryonic lethal in mouse. | Mouse Idh3b-/-: no retinal phenotype by P180, but spermiogenesis impaired; Idh3a null: embryonic lethal. | (findlay2018mouseidh3amutations pages 4-6, findlay2018mouseidh3amutations pages 1-4, findlay2018mouseidh3amutations pages 8-11) |
| Quantitative notes | Measured relative activities of partial dimers versus heterotetramer indicate strong subunit‑dependent activity differences; subunit expression shifts reported in testes of KO models. | α–γ dimers ≈ 36% of heterotetramer activity; α–β dimers ≈ 16% activity; KO testes showed ~75% reduction in IDH3A and ~35% increase in IDH3G (reported experimentally). | (findlay2018mouseidh3amutations pages 11-13, zhu2022isocitratedehydrogenase3b pages 1-2) |
| Recent insights (2022–2024) | 2022 JBC study (Zhu et al.): IDH3B required for spermiogenesis; 2018 mouse work highlighted retina sensitivity to IDH3 perturbation; 2023–2024 reviews/gene panels note IDH3B in IRD gene lists and discuss subunit roles in metabolism and disease. | Key recent publications: Zhu et al. 2022 (JBC); Findlay et al. 2018 (DMM); review/clinical panel mentions in 2023–2024 literature. | (zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2) |
Table: Compact, evidence‑linked summary of human IDH3B (UniProt O43837) covering identity, enzymatic role, complex structure, localization, regulation, pathway context, disease links, model differences, quantitative notes, and recent (2022–2024) findings; sources cite gathered evidence identifiers for traceability.
Mandatory verification and ambiguity check
- Gene symbol match and organism: The literature consistently uses IDH3B to denote the β subunit of mitochondrial NAD‑dependent IDH3 in mammals/humans, matching UniProt O43837 and Homo sapiens (https://doi.org/10.1016/j.jbc.2022.102387; https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
- Domain/family concordance: Reported function, localization, and complex assembly are coherent with isocitrate dehydrogenase family/domain annotations provided, and no conflicting gene symbol usage was found in the curated sources cited (https://doi.org/10.1016/j.jbc.2022.102387; https://doi.org/10.1242/dmm.036426; https://doi.org/10.3390/cancers15112883) (zhu2022isocitratedehydrogenase3b pages 1-2, findlay2018mouseidh3amutations pages 4-6, solomou2023mutantidhin pages 1-2).
References (URLs and dates)
- Zhu et al., 2022, Journal of Biological Chemistry. “Isocitrate dehydrogenase 3b is required for spermiogenesis but dispensable for retinal viability.” Published Sep 2022. URL: https://doi.org/10.1016/j.jbc.2022.102387 (zhu2022isocitratedehydrogenase3b pages 1-2).
- Findlay et al., 2018, Disease Models & Mechanisms. “Mouse Idh3a mutations cause retinal degeneration and reduced mitochondrial function.” Published Dec 2018. URL: https://doi.org/10.1242/dmm.036426 (findlay2018mouseidh3amutations pages 4-6, findlay2018mouseidh3amutations pages 11-13, findlay2018mouseidh3amutations pages 18-20, findlay2018mouseidh3amutations pages 1-4, findlay2018mouseidh3amutations pages 8-11).
- Solomou et al., 2023, Cancers. “Mutant IDH in Gliomas: Role in Cancer and Treatment Options.” Published May 2023. URL: https://doi.org/10.3390/cancers15112883 (solomou2023mutantidhin pages 1-2, solomou2023mutantidhin pages 9-10).
Limitations
- While multiple 2023–2024 sources discuss IDH enzymes and retinal disease broadly, specific new primary human IDH3B variant case series from 2023–2024 were not captured in the curated evidence set above. Where possible, we emphasized 2023 review coverage and 2022 functional genetics aligned to human biology (solomou2023mutantidhin pages 1-2, zhu2022isocitratedehydrogenase3b pages 1-2).
References
(zhu2022isocitratedehydrogenase3b pages 1-2): Siyan Zhu, Jiancheng Huang, Rong Xu, Yekai Wang, Yiming Wan, Rachel McNeel, Edward A. Parker, Douglas R. Kolson, M. Yam, Bradley A. Webb, Chen Zhao, Jenna Sigado, and Jianhai Du. Isocitrate dehydrogenase 3b is required for spermiogenesis but dispensable for retinal viability. Journal of Biological Chemistry, 298:102387, Sep 2022. URL: https://doi.org/10.1016/j.jbc.2022.102387, doi:10.1016/j.jbc.2022.102387. This article has 28 citations and is from a domain leading peer-reviewed journal.
(findlay2018mouseidh3amutations pages 4-6): Amy S. Findlay, Roderick N. Carter, Becky Starbuck, Lisa McKie, Klára Nováková, Peter S. Budd, Margaret A. Keighren, Joseph A. Marsh, Sally H. Cross, Michelle M. Simon, Paul K. Potter, Nicholas M. Morton, and Ian J. Jackson. Mouse idh3a mutations cause retinal degeneration and reduced mitochondrial function. Disease Models & Mechanisms, Dec 2018. URL: https://doi.org/10.1242/dmm.036426, doi:10.1242/dmm.036426. This article has 35 citations and is from a domain leading peer-reviewed journal.
(solomou2023mutantidhin pages 1-2): Georgios Solomou, Alina Finch, Asim Asghar, and Chiara Bardella. Mutant idh in gliomas: role in cancer and treatment options. Cancers, May 2023. URL: https://doi.org/10.3390/cancers15112883, doi:10.3390/cancers15112883. This article has 49 citations and is from a poor quality or predatory journal.
(solomou2023mutantidhin pages 9-10): Georgios Solomou, Alina Finch, Asim Asghar, and Chiara Bardella. Mutant idh in gliomas: role in cancer and treatment options. Cancers, May 2023. URL: https://doi.org/10.3390/cancers15112883, doi:10.3390/cancers15112883. This article has 49 citations and is from a poor quality or predatory journal.
(findlay2018mouseidh3amutations pages 11-13): Amy S. Findlay, Roderick N. Carter, Becky Starbuck, Lisa McKie, Klára Nováková, Peter S. Budd, Margaret A. Keighren, Joseph A. Marsh, Sally H. Cross, Michelle M. Simon, Paul K. Potter, Nicholas M. Morton, and Ian J. Jackson. Mouse idh3a mutations cause retinal degeneration and reduced mitochondrial function. Disease Models & Mechanisms, Dec 2018. URL: https://doi.org/10.1242/dmm.036426, doi:10.1242/dmm.036426. This article has 35 citations and is from a domain leading peer-reviewed journal.
(findlay2018mouseidh3amutations pages 8-11): Amy S. Findlay, Roderick N. Carter, Becky Starbuck, Lisa McKie, Klára Nováková, Peter S. Budd, Margaret A. Keighren, Joseph A. Marsh, Sally H. Cross, Michelle M. Simon, Paul K. Potter, Nicholas M. Morton, and Ian J. Jackson. Mouse idh3a mutations cause retinal degeneration and reduced mitochondrial function. Disease Models & Mechanisms, Dec 2018. URL: https://doi.org/10.1242/dmm.036426, doi:10.1242/dmm.036426. This article has 35 citations and is from a domain leading peer-reviewed journal.
(findlay2018mouseidh3amutations pages 1-4): Amy S. Findlay, Roderick N. Carter, Becky Starbuck, Lisa McKie, Klára Nováková, Peter S. Budd, Margaret A. Keighren, Joseph A. Marsh, Sally H. Cross, Michelle M. Simon, Paul K. Potter, Nicholas M. Morton, and Ian J. Jackson. Mouse idh3a mutations cause retinal degeneration and reduced mitochondrial function. Disease Models & Mechanisms, Dec 2018. URL: https://doi.org/10.1242/dmm.036426, doi:10.1242/dmm.036426. This article has 35 citations and is from a domain leading peer-reviewed journal.
(findlay2018mouseidh3amutations pages 18-20): Amy S. Findlay, Roderick N. Carter, Becky Starbuck, Lisa McKie, Klára Nováková, Peter S. Budd, Margaret A. Keighren, Joseph A. Marsh, Sally H. Cross, Michelle M. Simon, Paul K. Potter, Nicholas M. Morton, and Ian J. Jackson. Mouse idh3a mutations cause retinal degeneration and reduced mitochondrial function. Disease Models & Mechanisms, Dec 2018. URL: https://doi.org/10.1242/dmm.036426, doi:10.1242/dmm.036426. This article has 35 citations and is from a domain leading peer-reviewed journal.
id: O43837
gene_symbol: IDH3B
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
IDH3B encodes the beta subunit of mitochondrial NAD-dependent isocitrate dehydrogenase 3 (IDH3).
The functional IDH3 enzyme is a heterotetramer with alpha2-beta-gamma stoichiometry (2alpha:1beta:1gamma),
where the alpha subunits (IDH3A) are catalytic, while beta (IDH3B) and gamma (IDH3G) play structural
and regulatory roles. IDH3B does NOT have intrinsic catalytic activity on its own - expression of
beta subunit alone shows no detectable activity [PMID:10601238]. The alphabeta and alphagamma dimers
exhibit significant IDH activity, but the full heterotetramer is required for maximal activity and
proper allosteric regulation [PMID:14555658]. The IDH3 complex catalyzes the irreversible oxidative
decarboxylation of isocitrate to alpha-ketoglutarate in the TCA cycle. Beta-Arg99 is required for
normal ADP activation of the enzyme but is not essential for catalysis [PMID:14555658]. IDH3B localizes
to the mitochondrial matrix. Biallelic variants cause retinitis pigmentosa 46 (RP46). IDH3B exists
as multiple isoforms (beta1 and beta2) due to alternative splicing, with tissue-specific expression
patterns affecting the pH optimum of the enzyme complex [PMID:10601238].
alternative_products:
- name: B
id: O43837-1
- name: A
id: O43837-2
sequence_note: VSP_002462
- name: C
id: O43837-3
sequence_note: VSP_041335
existing_annotations:
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IDH3B is well-established as a mitochondrial protein. The IBA annotation is phylogenetically
well-supported across eukaryotes. UniProt indicates a mitochondrial transit peptide (residues
1-34) and documents mitochondrial localization. PMID:10601238 describes IDH3B as part of
"mitochondrial NAD(+)-dependent isocitrate dehydrogenase" and discusses its function in
the context of mitochondrial enzyme complexes.
action: ACCEPT
reason: >-
Mitochondrial localization is correct and well-supported by phylogenetic inference, UniProt
annotation, and experimental literature. While mitochondrial matrix (GO:0005759) is more
precise, this broader term is acceptable for the IBA evidence type.
supported_by:
- reference_id: PMID:10601238
supporting_text: "the interactions and functional role of each of the three mitochondrial NAD(+)-dependent isocitrate dehydrogenase (IDH) subunits (alpha, beta, and gamma)"
- term:
id: GO:0006099
label: tricarboxylic acid cycle
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IDH3B is a component of the NAD-dependent isocitrate dehydrogenase complex that catalyzes
a key step of the TCA cycle. While the beta subunit is not itself catalytic, it is essential
for proper complex assembly and function in the TCA cycle [PMID:10601238, PMID:14555658].
The IBA annotation appropriately captures the involvement of IDH3B in this process.
action: ACCEPT
reason: >-
As an essential structural component of the IDH3 complex, IDH3B participates in the TCA
cycle even though it lacks intrinsic catalytic activity. The phylogenetic evidence
supports this annotation across eukaryotes.
supported_by:
- reference_id: PMID:10601238
supporting_text: "Among the various combinations of human IDH subunits co-expressed in bacteria, alphabetagamma, alphabeta, and alphagamma combinations exhibited significant amounts of IDH activity"
- term:
id: GO:0006102
label: isocitrate metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IDH3B participates in isocitrate metabolism as part of the IDH3 complex. The complex
converts isocitrate to alpha-ketoglutarate. While IDH3B is not the catalytic subunit,
it is required for proper complex assembly and activity [PMID:10601238].
action: ACCEPT
reason: >-
The annotation correctly captures IDH3B's involvement in isocitrate metabolism through
its role in the IDH3 complex. Well-supported by phylogenetic analysis.
supported_by:
- reference_id: PMID:10601238
supporting_text: "the alpha is the catalytic subunit and that at least one of the other two subunits plays an essential supporting role for activity"
- term:
id: GO:0000287
label: magnesium ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
This annotation is inferred from InterPro domain IPR019818 (IsoCit/isopropylmalate_DH_CS).
However, in the IDH3 complex, Mg2+ (or Mn2+) binding occurs at the active site in the
catalytic alpha subunit, not in the structural beta subunit. The deep research notes
that the enzyme "is a heterooctamer containing two copies of a heterotetramer of two
IDH3A, one IDH3B, one IDH3G, and two Mn++" [Reactome:R-HSA-70967], suggesting metal
binding is associated with the catalytic subunits. No direct evidence supports
magnesium binding by IDH3B specifically. The crystal structures of the αβ heterodimer
(PDB 6KDE Ca2+-bound, 6KDY NAD-bound) place the divalent metal site at the active-site
cleft contributed by the α subunit; the β subunit does not provide a productive metal
site, and in the αβ heterodimer the active site has a distorted geometry unable to bind
the metal ion in a catalysis-relevant manner [PMID:31515270].
action: MARK_AS_OVER_ANNOTATED
reason: >-
While the InterPro domain is present, the functional magnesium/metal binding site is
located in the catalytic alpha subunit. IDH3B shares sequence/structural homology with
dehydrogenases but its specific role is structural, not catalytic. This IEA annotation
represents domain-based inference that does not reflect the actual function of this
specific subunit.
supported_by:
- reference_id: PMID:31515270
supporting_text: "the active site has a distorted geometry that is unable to bind the metal ion effectively or in a catalysis-relevant manner"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
Mitochondrial localization inferred from UniProt subcellular location annotation.
This is consistent with experimental evidence and the IBA annotation above.
action: ACCEPT
reason: >-
Correct annotation based on UniProt curation. IDH3B has a mitochondrial transit
peptide and functions in the mitochondrial matrix.
- term:
id: GO:0006099
label: tricarboxylic acid cycle
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
Combined automated annotation correctly identifies IDH3B's involvement in the TCA cycle.
Consistent with IBA annotation and experimental literature.
action: ACCEPT
reason: >-
Correct annotation. IDH3B is part of the IDH3 complex that catalyzes a key TCA cycle step.
- term:
id: GO:0016616
label: oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
This annotation is inferred from InterPro domain IPR019818. However, PMID:10601238
demonstrates that "subunits produced alone ... showed no detectable activity" and
establishes that "the alpha is the catalytic subunit." IDH3B shares the dehydrogenase
domain but does not itself possess oxidoreductase activity - it is a structural/
regulatory subunit of the complex.
action: REMOVE
reason: >-
IDH3B does not have intrinsic oxidoreductase activity. The beta subunit alone shows
no detectable enzymatic activity [PMID:10601238]. This annotation incorrectly attributes
the catalytic activity of the complex to the non-catalytic beta subunit based solely
on domain homology.
supported_by:
- reference_id: PMID:10601238
supporting_text: "subunits produced alone and betagamma showed no detectable activity. These data suggest that the alpha is the catalytic subunit"
- term:
id: GO:0051287
label: NAD binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
This annotation is inferred from InterPro domain IPR019818. While IDH3B shares
structural homology with NAD-binding dehydrogenases, the functional NAD binding and
catalysis occurs in the alpha subunit. PMID:14555658 shows that mutations in the
gamma subunit affect NAD binding (gamma-R97Q has 10-fold higher Km for NAD), but
the beta subunit's role is in ADP activation, not NAD binding at the catalytic site.
However, the beta subunit may contribute to the nucleotide binding pocket architecture.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The annotation is based on domain homology rather than demonstrated function.
IDH3B contributes to the complex structure and ADP-mediated regulation but is not
itself the primary NAD-binding subunit. The catalytic NAD binding site is in IDH3A.
Crystal structures of the alphabeta heterodimer (PDB 6KDY NAD-bound, 6KE3 NADH-bound)
show that the NAD cofactor binds in the active-site cleft built jointly from the alpha
subunit and the small domain of the beta subunit, so the beta subunit contributes to
the architecture of the holoenzyme NAD-binding/active site rather than binding NAD as
an isolated subunit [PMID:31515270].
supported_by:
- reference_id: PMID:14555658
supporting_text: "the beta and gamma subunits have roles in the nucleotide functions of this allosteric enzyme"
- reference_id: PMID:31515270
supporting_text: "We report here the crystal structures of the αβ heterodimer of human NAD-IDH with the α subunit in apo form and in Ca2+-bound, NAD-bound, and NADH-bound forms"
- reference_id: PMID:31515270
supporting_text: "The active site is located in the cleft formed by the large and small domains of the α subunit and the small domain of the β subunit"
- reference_id: PMID:36375638
supporting_text: "the αQ139AICT+Ca+NADβNAD structure presents the first pseudo-Michaelis complex of HsIDH3, which allows us to identify the key residues involved in the binding of cofactor, substrate, and metal ion"
- term:
id: GO:0045242
label: isocitrate dehydrogenase complex (NAD+)
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IDH3B is a core component of the NAD-dependent isocitrate dehydrogenase complex.
The complex has 2alpha:1beta:1gamma stoichiometry [PMID:14555658]. This cellular
component annotation is entirely appropriate for IDH3B. Crystal structures of the
human IDH3 alphabeta heterodimer (PDB 6KDE/6KDF/6KDY/6KE3) and of the constitutively
active (αβαγ)2 holoenzyme (PDB 8GRB) directly establish IDH3B (beta) as an assembled
subunit of the IDH3 complex and define the alpha-beta heterodimer interface
[PMID:31515270, PMID:36375638].
action: ACCEPT
reason: >-
Correct annotation. IDH3B is an established subunit of the IDH3 complex, confirmed
by co-expression studies and structural analysis.
supported_by:
- reference_id: PMID:14555658
supporting_text: "Wild type (WT) and mutant enzymes ... were purified to homogeneity yielding enzymes with 2alpha:1beta:1gamma subunit composition"
- reference_id: PMID:31515270
supporting_text: "The α and β subunits form a heterodimer (αβ), and the α and γ subunits form another heterodimer (αγ), which are assembled into a heterotetramer (α2βγ) and further into a heterooctamer"
- reference_id: PMID:36375638
supporting_text: "It consists of three types of subunits (α, β, and γ) and exists and functions as the (αβαγ)2 heterooctamer"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: >-
Direct experimental evidence for mitochondrial localization from HPA immunofluorescence
data. This provides direct experimental support for the mitochondrial localization.
action: ACCEPT
reason: >-
Direct experimental evidence (IDA from immunofluorescence) confirms mitochondrial
localization, consistent with all other evidence sources.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: NAS
original_reference_id: PMID:14555658
review:
summary: >-
PMID:14555658 is a study of human NAD-dependent isocitrate dehydrogenase expressed
in bacteria. The paper discusses the enzyme's function in the context of mitochondrial
metabolism but does not directly demonstrate mitochondrial localization - hence NAS
(non-traceable author statement) is appropriate.
action: ACCEPT
reason: >-
While the evidence is indirect, mitochondrial localization is well-established from
multiple other sources. This annotation is consistent with the overall body of evidence.
supported_by:
- reference_id: PMID:14555658
supporting_text: "Mammalian NAD-dependent isocitrate dehydrogenase is an allosteric enzyme"
- term:
id: GO:0006099
label: tricarboxylic acid cycle
evidence_type: IDA
original_reference_id: PMID:14555658
review:
summary: >-
PMID:14555658 demonstrates that the IDH3 complex including the beta subunit has
isocitrate dehydrogenase activity, which is a key TCA cycle reaction. The study
shows IDH activity of purified complexes containing beta subunit [PMID:14555658].
action: ACCEPT
reason: >-
Direct experimental evidence that IDH3B-containing complexes have isocitrate
dehydrogenase activity, supporting involvement in TCA cycle.
supported_by:
- reference_id: PMID:14555658
supporting_text: "Specific activities of 22, 14, and 2 micromol of NADH/min/mg were measured, respectively, for WT, beta-R99Q, and gamma-R97Q enzymes"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
review:
summary: >-
PMID:34800366 is a high-throughput mitochondrial proteomics study that identified
IDH3B in the human mitochondrial proteome. This provides orthogonal mass spectrometry-
based evidence for mitochondrial localization.
action: ACCEPT
reason: >-
High-quality proteomics study confirming IDH3B presence in the mitochondrial proteome.
supported_by:
- reference_id: PMID:34800366
supporting_text: "Quantitative high-confidence human mitochondrial proteome"
- term:
id: GO:0045242
label: isocitrate dehydrogenase complex (NAD+)
evidence_type: IDA
original_reference_id: PMID:14555658
review:
summary: >-
PMID:14555658 provides direct experimental evidence that IDH3B is a component of
the IDH3 complex. The study purified the complex and demonstrated the 2alpha:1beta:1gamma
stoichiometry through expression and biochemical analysis. Crystal structures of the
human IDH3 alphabeta heterodimer (PDB 6KDE/6KDF/6KDY NAD-bound/6KE3 NADH-bound) and of the
constitutively active (alphabeta-alphagamma)2 holoenzyme (PDB 8GRB) directly visualize
IDH3B (beta) as an assembled subunit of the IDH3 complex and define the alpha-beta
heterodimer interface [PMID:31515270, PMID:36375638].
action: ACCEPT
reason: >-
Direct experimental demonstration that IDH3B is part of the IDH3 complex with
defined stoichiometry.
supported_by:
- reference_id: PMID:14555658
supporting_text: "Wild type (WT) and mutant enzymes (each containing 2 normal subunits plus a mutant subunit with alpha-R88Q, beta-R99Q, or gamma-R97Q) were purified to homogeneity yielding enzymes with 2alpha:1beta:1gamma subunit composition and a native molecular mass of 315 kDa"
- reference_id: PMID:31515270
supporting_text: "The α and β subunits form a heterodimer (αβ), and the α and γ subunits form another heterodimer (αγ), which are assembled into a heterotetramer (α2βγ) and further into a heterooctamer"
- reference_id: PMID:36375638
supporting_text: "It consists of three types of subunits (α, β, and γ) and exists and functions as the (αβαγ)2 heterooctamer"
- term:
id: GO:0005634
label: nucleus
evidence_type: HDA
original_reference_id: PMID:21630459
review:
summary: >-
PMID:21630459 is a proteomic study of the human sperm nucleus that identified IDH3B
among 403 nuclear proteins. This is a specialized cell type where metabolic proteins
may be present in the nuclear fraction during spermatogenesis. The nuclear localization
is likely context-specific rather than representing a core localization.
action: KEEP_AS_NON_CORE
reason: >-
The detection in sperm nuclear proteome may represent a specialized developmental
context. IDH3B's primary localization is mitochondrial, and nuclear detection may
reflect the unique chromatin remodeling during spermiogenesis or technical
co-purification. This is not a core localization but should be retained.
supported_by:
- reference_id: PMID:21630459
supporting_text: "403 different proteins have been identified from the isolated sperm nuclei"
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-70967
review:
summary: >-
Reactome pathway R-HSA-70967 "IDH3 complex decarboxylates isocitrate" places the
IDH3 complex, including IDH3B, in the mitochondrial matrix. This is the most specific
and accurate localization for IDH3B's function.
action: ACCEPT
reason: >-
Mitochondrial matrix is the precise subcellular location where IDH3 functions in
the TCA cycle. This is the most informative localization annotation for IDH3B.
- term:
id: GO:0009055
label: electron transfer activity
evidence_type: TAS
original_reference_id: PMID:10601238
review:
summary: >-
PMID:10601238 does not support electron transfer activity for IDH3B. The paper
demonstrates that the IDH3 complex has isocitrate dehydrogenase activity (reducing
NAD+ to NADH), but this is not the same as electron transfer activity. Electron
transfer activity (GO:0009055) refers to proteins that function as electron carriers
(like cytochromes or ferredoxins), not dehydrogenases that use NAD+ as a cofactor.
Furthermore, IDH3B specifically is the non-catalytic subunit.
action: REMOVE
reason: >-
Incorrect annotation. GO:0009055 (electron transfer activity) is inappropriate for
IDH3B. The NAD+-dependent dehydrogenase reaction is not electron transfer activity
in the GO sense. Additionally, IDH3B is not catalytically active - the paper states
"subunits produced alone ... showed no detectable activity."
supported_by:
- reference_id: PMID:10601238
supporting_text: "subunits produced alone and betagamma showed no detectable activity"
- term:
id: GO:0004449
label: isocitrate dehydrogenase (NAD+) activity
evidence_type: TAS
original_reference_id: PMID:10601238
review:
summary: >-
PMID:10601238 explicitly demonstrates that IDH3B alone does not have isocitrate
dehydrogenase activity. The paper states "subunits produced alone and betagamma
showed no detectable activity" and concludes that "the alpha is the catalytic subunit."
While the alphabeta dimer has activity, this is due to the alpha subunit, not beta.
action: REMOVE
reason: >-
The cited paper PMID:10601238 directly contradicts this annotation. IDH3B does not
have intrinsic isocitrate dehydrogenase activity. The beta subunit is structural/
regulatory, and attributing the catalytic activity to it is incorrect. This is a
case where the annotation was likely made at the complex level and incorrectly
propagated to the non-catalytic subunit.
supported_by:
- reference_id: PMID:10601238
supporting_text: "subunits produced alone and betagamma showed no detectable activity. These data suggest that the alpha is the catalytic subunit and that at least one of the other two subunits plays an essential supporting role for activity"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: TAS
original_reference_id: PMID:10601238
review:
summary: >-
PMID:10601238 describes IDH3B as part of "mitochondrial NAD(+)-dependent isocitrate
dehydrogenase" and discusses it in the context of mitochondrial function. The
mitochondrial localization is well-supported.
action: ACCEPT
reason: >-
The paper describes IDH3B as a mitochondrial protein. Consistent with all other
evidence for mitochondrial localization.
supported_by:
- reference_id: PMID:10601238
supporting_text: "the interactions and functional role of each of the three mitochondrial NAD(+)-dependent isocitrate dehydrogenase (IDH) subunits"
- term:
id: GO:0006102
label: isocitrate metabolic process
evidence_type: TAS
original_reference_id: PMID:10601238
review:
summary: >-
PMID:10601238 demonstrates that IDH3B contributes to isocitrate metabolism as part
of the IDH3 complex. While IDH3B is not catalytic, it plays "an essential supporting
role for activity" in isocitrate oxidation.
action: ACCEPT
reason: >-
IDH3B participates in isocitrate metabolism through its essential structural role
in the IDH3 complex. The paper demonstrates that beta-containing complexes have
isocitrate dehydrogenase activity.
supported_by:
- reference_id: PMID:10601238
supporting_text: "alphabetagamma, alphabeta, and alphagamma combinations exhibited significant amounts of IDH activity"
- term:
id: GO:0005198
label: structural molecule activity
evidence_type: NAS
original_reference_id: PMID:10601238
review:
summary: >-
IDH3B functions as a structural subunit of the IDH3 complex. PMID:10601238 demonstrates
that the beta subunit alone has no catalytic activity ("subunits produced alone and
betagamma showed no detectable activity") but plays "an essential supporting role for
activity." The beta subunit is required for proper complex assembly and function. Deep
research confirms that IDH3B plays a structural/regulatory role in the heterotetramer
[file:human/IDH3B/IDH3B-deep-research-falcon.md].
action: NEW
reason: >-
This annotation captures IDH3B's established role as a structural component of the
IDH3 enzyme complex. The term GO:0005198 is defined as "The action of a molecule
that contributes to the structural integrity of a complex" which accurately describes
IDH3B's function. This is a more appropriate molecular function annotation than
the catalytic activity terms that were incorrectly attributed to IDH3B.
supported_by:
- reference_id: PMID:10601238
supporting_text: "These data suggest that the alpha is the catalytic subunit and that at least one of the other two subunits plays an essential supporting role for activity"
- reference_id: file:human/IDH3B/IDH3B-deep-research-falcon.md
supporting_text: "IDH3B appears to play a structural/regulatory role in the complex, as opposed to a catalytic one"
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings:
- statement: InterPro domain IPR019818 (IsoCit/isopropylmalate_DH_CS) is present in IDH3B but catalytic residues are in the alpha subunit
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings:
- statement: Phylogenetic analysis supports IDH3B mitochondrial localization and TCA cycle involvement across eukaryotes
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
findings:
- statement: UniProt documents mitochondrial localization with transit peptide
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings:
- statement: HPA immunofluorescence confirms mitochondrial localization
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
findings:
- statement: Complex membership annotation transferred from mouse ortholog
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings:
- statement: Automated methods correctly identify TCA cycle involvement
- id: PMID:10601238
title: Identification and functional characterization of a novel, tissue-specific NAD(+)-dependent isocitrate dehydrogenase beta subunit isoform.
findings:
- statement: IDH3B exists as two isoforms (beta1 and beta2) due to alternative splicing
supporting_text: "the smaller beta(2) transcript (1.3 kilobases) is primarily expressed in heart and skeletal muscle, whereas the larger beta(1) mRNA (1.6 kilobases) is prevalent in nonmuscle tissues"
- statement: Beta subunit alone has no detectable IDH activity
supporting_text: "subunits produced alone and betagamma showed no detectable activity"
- statement: Alpha is the catalytic subunit
supporting_text: "These data suggest that the alpha is the catalytic subunit and that at least one of the other two subunits plays an essential supporting role for activity"
- statement: Alphabeta and alphagamma dimers have IDH activity
supporting_text: "alphabetagamma, alphabeta, and alphagamma combinations exhibited significant amounts of IDH activity"
- statement: Beta isoforms affect pH optimum of enzyme activity
supporting_text: "Substitution of beta(1) with beta(2) in the co-expression system lowered the pH optimum for IDH activity from 8.0 to 7.6"
- id: PMID:14555658
title: Evaluation by mutagenesis of the importance of 3 arginines in alpha, beta, and gamma subunits of human NAD-dependent isocitrate dehydrogenase.
findings:
- statement: IDH3 complex has 2alpha:1beta:1gamma stoichiometry with 315 kDa molecular mass
supporting_text: "Wild type (WT) and mutant enzymes ... were purified to homogeneity yielding enzymes with 2alpha:1beta:1gamma subunit composition and a native molecular mass of 315 kDa"
- statement: Beta-R99Q mutant retains 64% of wild-type activity (14 vs 22 micromol NADH/min/mg)
supporting_text: "Specific activities of 22, 14, and 2 micromol of NADH/min/mg were measured, respectively, for WT, beta-R99Q, and gamma-R97Q enzymes"
- statement: Beta-Arg99 is required for normal ADP activation but not essential for catalysis
supporting_text: "for beta-R99Q and gamma-R97Q enzymes, the Km for isocitrate is the same in the absence or presence of ADP, although all the enzymes bind ADP"
- statement: Alpha-Arg88 is essential for catalysis (alpha-R88Q has no activity)
supporting_text: "mutant enzymes with normal beta and gamma subunits and alpha-R88Q mutant subunit has no detectable activity, demonstrating that ... alpha-Arg88 is essential for catalysis"
- statement: Beta and gamma subunits have roles in nucleotide functions of the allosteric enzyme
supporting_text: "the beta and gamma subunits have roles in the nucleotide functions of this allosteric enzyme"
- id: PMID:31515270
title: Molecular basis for the function of the αβ heterodimer of human NAD-dependent isocitrate dehydrogenase.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Crystal structures (PDB 6KDF apo, 6KDE Ca2+-bound, 6KDY NAD-bound, 6KE3 NADH-bound) of the human
IDH3 αβ heterodimer establish IDH3B (β) as an assembled subunit whose small domain helps form the
active-site cleft and whose β3-α3/β12-α8 loops build a pseudo-allosteric site, defining β's
structural/regulatory contribution to NAD/NADH binding, metal-ion geometry, and allosteric control
of the holoenzyme rather than any catalytic activity of β alone.
findings:
- statement: Crystal structures of the human NAD-IDH αβ heterodimer determined in apo, Ca2+-bound, NAD-bound, and NADH-bound forms
supporting_text: "We report here the crystal structures of the αβ heterodimer of human NAD-IDH with the α subunit in apo form and in Ca2+-bound, NAD-bound, and NADH-bound forms"
- statement: The active site is formed jointly by the α subunit large/small domains and the β subunit small domain
supporting_text: "The active site is located in the cleft formed by the large and small domains of the α subunit and the small domain of the β subunit"
- statement: In the αβ heterodimer the active site has a distorted geometry unable to bind the metal ion productively
supporting_text: "the active site has a distorted geometry that is unable to bind the metal ion effectively or in a catalysis-relevant manner"
- id: PMID:36375638
title: Structures of a constitutively active mutant of human IDH3 reveal new insights into the mechanisms of allosteric activation and the catalytic reaction.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Structures of the constitutively active α-Q139A mutant, including the (αβαγ)2 holoenzyme (PDB 8GRB)
and the first pseudo-Michaelis complex of HsIDH3, place IDH3B as an integral β subunit of the active
heterooctamer and define the cofactor/substrate/metal-binding residues at the complex level,
supporting β's role in holoenzyme assembly, allosteric activation, and the catalytic reaction.
findings:
- statement: Human IDH3 functions as the (αβαγ)2 heterooctamer composed of α, β, and γ subunits
supporting_text: "It consists of three types of subunits (α, β, and γ) and exists and functions as the (αβαγ)2 heterooctamer"
- statement: Structures provide the first pseudo-Michaelis complex of HsIDH3 identifying cofactor, substrate, and metal-ion binding residues
supporting_text: "the αQ139AICT+Ca+NADβNAD structure presents the first pseudo-Michaelis complex of HsIDH3, which allows us to identify the key residues involved in the binding of cofactor, substrate, and metal ion"
- id: PMID:21630459
title: Proteomic characterization of the human sperm nucleus.
findings:
- statement: IDH3B detected in sperm nuclear proteome among 403 proteins
supporting_text: "403 different proteins have been identified from the isolated sperm nuclei"
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
findings:
- statement: High-throughput proteomics confirms IDH3B in mitochondrial proteome
supporting_text: "Quantitative high-confidence human mitochondrial proteome"
- id: Reactome:R-HSA-70967
title: IDH3 complex decarboxylates isocitrate
findings:
- statement: IDH3 complex catalyzes isocitrate + NAD+ to alpha-ketoglutarate + CO2 + NADH in mitochondrial matrix
supporting_text: "Mitochondrial isocitrate dehydrogenase IDH3 catalyzes the irreversible reaction of isocitrate and NAD+ to form alpha-ketoglutarate, CO2, and NADH"
- statement: Complex is heterooctamer with 2alpha:1beta:1gamma heterotetramer repeated twice plus Mn++
supporting_text: "The enzyme is a heterooctamer containing two copies of a heterotetramer of two IDH3A, one IDH3B, one IDH3G, and two Mn++"
- statement: Activated by ADP, inhibited by NADH and high ATP
supporting_text: "It is activated by ADP (Soundar et al., 2003, 2006; Bzymek and Colman, 2007) and inhibited by NADH and high concentrations of ATP"
- id: file:human/IDH3B/IDH3B-deep-research-falcon.md
title: Deep research summary for IDH3B
findings:
- statement: IDH3 complex has alpha2-beta-gamma stoichiometry where beta plays structural/regulatory role
- statement: AlphaBeta dimer has ~16% of heterotetramer activity while AlphaGamma dimer has ~36%
- statement: Allosteric regulation by citrate and ADP occurs through gamma subunit, not beta
- statement: IDH3B required for spermiogenesis in mouse knockout studies
- statement: Biallelic IDH3B variants cause retinitis pigmentosa 46
core_functions:
- description: >-
IDH3B functions as a structural/regulatory subunit of the mitochondrial NAD-dependent
isocitrate dehydrogenase complex. It does not have intrinsic catalytic activity but is
essential for proper complex assembly, stability, and allosteric regulation. The beta
subunit contributes to ADP-mediated activation of the enzyme.
molecular_function:
id: GO:0005198
label: structural molecule activity
directly_involved_in:
- id: GO:0006099
label: tricarboxylic acid cycle
locations:
- id: GO:0005759
label: mitochondrial matrix
in_complex:
id: GO:0045242
label: isocitrate dehydrogenase complex (NAD+)
supported_by:
- reference_id: PMID:14555658
supporting_text: "Wild type (WT) and mutant enzymes ... were purified to homogeneity yielding enzymes with 2alpha:1beta:1gamma subunit composition"
- reference_id: PMID:10601238
supporting_text: "the alpha is the catalytic subunit and that at least one of the other two subunits plays an essential supporting role for activity"
suggested_questions:
- question: >-
Within the αβαγ heterotetramer (and its (αβαγ)2 holoenzyme), which IDH3B residues
beyond β-Arg99 transmit the ADP allosteric signal to the IDH3A catalytic site, and
does IDH3B contribute any direct interactions to substrate/cofactor binding in the
pseudo-Michaelis complex captured by the αQ139A·ICT·Ca·NAD·βNAD structure (PMID:36375638)?
Mapping these residues would justify more specific molecular-function annotations
for IDH3B (e.g., positive regulation of isocitrate dehydrogenase activity).
- question: >-
What is the functional consequence of β1 vs β2 isoform switching in vivo? Beyond
the shifted pH optimum from 8.0 to 7.6 in vitro (PMID:10601238), do heart and
skeletal muscle preferentially run IDH3 at distinct intramitochondrial pH set
points, and is this isoform exchange dynamic with physiological state (exercise,
ischemia)?
- question: >-
Why does loss of IDH3B selectively manifest as retinitis pigmentosa 46 when IDH3
operates ubiquitously? Is the retinal phenotype driven by a uniquely high
photoreceptor TCA flux, by altered NADH/NAD+ balance affecting outer-segment
lipid/visual-cycle pathways, or by α2γ-only complexes acting as a partial-loss-of-
function background that other tissues tolerate?
suggested_experiments:
- description: >-
Reconstitute the recombinant (αβαγ)2 holoenzyme with IDH3B variants spanning the
β3-α3 and β12-α8 loops identified in PMID:31515270 / PMID:36375638 as building the
pseudo-allosteric site, and measure ADP-dependent k_cat / K_m for isocitrate plus
ADP-binding affinity by ITC. Pair with cryo-EM of selected variants in the apo and
ADP-bound states to confirm structural consequences.
hypothesis: >-
The pseudo-allosteric loops contributed by IDH3B (small domain plus β3-α3 / β12-α8)
are the principal transducers of ADP activation, and engineered residue swaps in
these loops can uncouple ADP binding from catalytic activation.
experiment_type: biochemistry / structural biology
- description: >-
Generate isoform-specific β1 and β2 CRISPR knock-in HEK293, C2C12 (skeletal muscle)
and HL-1 (cardiomyocyte) lines and measure intramitochondrial pH, TCA flux (13C
isotopologue analysis of citrate/α-ketoglutarate), and oxygen consumption under
basal and exercised/hypoxic conditions.
hypothesis: >-
β2 expression in muscle tissue tunes IDH3 activity to a lower, physiologically
relevant matrix pH, supporting sustained TCA flux during high-workload conditions
where matrix pH falls below the β1 optimum.
experiment_type: cell biology / metabolomics
- description: >-
Patient-derived iPSC differentiation to retinal organoids from RP46 IDH3B
patients vs. isogenic CRISPR-corrected controls, with assessment of photoreceptor
survival, outer-segment morphology, NADH/NAD+ ratio, α-KG levels, and TCA flux.
Compare to iPSC-derived cardiomyocytes and hepatocytes from the same patients to
identify the metabolic axis that distinguishes the retina.
hypothesis: >-
Photoreceptor degeneration in RP46 is driven by NADH-dependent or α-KG-dependent
processes uniquely sensitive to partial IDH3 activity (e.g., visual-cycle retinoid
metabolism or HIF/2-oxoglutarate-dependent dioxygenase signalling) rather than by a
generalized TCA failure.
experiment_type: stem-cell biology / clinical model